Raines S, Falcinelli S, Peterson J, Van Gulck E, Allard B, Kirchherr J
Antimicrob Agents Chemother. 2024; 68(7):e0020124.
PMID: 38829049
PMC: 11232404.
DOI: 10.1128/aac.00201-24.
Kaempfer R
Genes (Basel). 2023; 14(5).
PMID: 37239334
PMC: 10218296.
DOI: 10.3390/genes14050974.
Namer L, Harwig A, Heynen S, Das A, Berkhout B, Kaempfer R
Cell Biosci. 2023; 13(1):28.
PMID: 36774495
PMC: 9922466.
DOI: 10.1186/s13578-023-00972-1.
Liu Y, Li L, Timani K, He J
Viruses. 2022; 14(5).
PMID: 35632716
PMC: 9143625.
DOI: 10.3390/v14050974.
Kim J, Chun H
Int J Mol Sci. 2021; 22(18).
PMID: 34576162
PMC: 8468913.
DOI: 10.3390/ijms22189998.
Inhibition of spumavirus gene expression by PHF11.
Kane M, Mele V, Liberatore R, Bieniasz P
PLoS Pathog. 2020; 16(7):e1008644.
PMID: 32678836
PMC: 7390438.
DOI: 10.1371/journal.ppat.1008644.
Genetic variation and function of the HIV-1 Tat protein.
Spector C, Mele A, Wigdahl B, Nonnemacher M
Med Microbiol Immunol. 2019; 208(2):131-169.
PMID: 30834965
PMC: 6476422.
DOI: 10.1007/s00430-019-00583-z.
Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure.
Tjitro R, Campbell L, Basova L, Johnson J, Najera J, Lindsey A
Front Immunol. 2019; 9:3110.
PMID: 30778358
PMC: 6369711.
DOI: 10.3389/fimmu.2018.03110.
Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
Wang M, Yang W, Chen Y, Wang J, Tan J, Qiao W
Retrovirology. 2018; 15(1):65.
PMID: 30241541
PMC: 6150996.
DOI: 10.1186/s12977-018-0447-9.
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
Shah S, Alexaki A, Pirrone V, Dahiya S, Nonnemacher M, Wigdahl B
Virol J. 2014; 11:92.
PMID: 24886416
PMC: 4047001.
DOI: 10.1186/1743-422X-11-92.
Viral factors in non-progression.
Wang B
Front Immunol. 2014; 4:355.
PMID: 24400003
PMC: 3871964.
DOI: 10.3389/fimmu.2013.00355.
ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.
Bruce J, Reddington R, Mathieu E, Bracken M, Young J, Ahlquist P
PLoS Pathog. 2013; 9(10):e1003712.
PMID: 24204263
PMC: 3812036.
DOI: 10.1371/journal.ppat.1003712.
SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase.
Ji X, Zhou Y, Pandit S, Huang J, Li H, Lin C
Cell. 2013; 153(4):855-68.
PMID: 23663783
PMC: 4103662.
DOI: 10.1016/j.cell.2013.04.028.
Novel biopanning strategy to identify epitopes associated with vaccine protection.
Bachler B, Humbert M, Palikuqi B, Siddappa N, Lakhashe S, Rasmussen R
J Virol. 2013; 87(8):4403-16.
PMID: 23388727
PMC: 3624354.
DOI: 10.1128/JVI.02888-12.
Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
DOrso I, Jang G, Pastuszak A, Faust T, Quezada E, Booth D
Mol Cell Biol. 2012; 32(23):4780-93.
PMID: 23007159
PMC: 3497596.
DOI: 10.1128/MCB.00206-12.
The HIV-1 Tat protein has a versatile role in activating viral transcription.
Das A, Harwig A, Berkhout B
J Virol. 2011; 85(18):9506-16.
PMID: 21752913
PMC: 3165771.
DOI: 10.1128/JVI.00650-11.
RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation.
DOrso I, Frankel A
Nat Struct Mol Biol. 2010; 17(7):815-21.
PMID: 20562857
PMC: 2921552.
DOI: 10.1038/nsmb.1827.
Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.
Shah S, Nonnemacher M, Pirrone V, Wigdahl B
J Neuroimmune Pharmacol. 2010; 5(3):278-93.
PMID: 20387125
PMC: 3057210.
DOI: 10.1007/s11481-010-9207-x.
Chromatin dynamics associated with HIV-1 Tat-activated transcription.
Easley R, Van Duyne R, Coley W, Guendel I, Dadgar S, Kehn-Hall K
Biochim Biophys Acta. 2009; 1799(3-4):275-85.
PMID: 19716452
PMC: 2838975.
DOI: 10.1016/j.bbagrm.2009.08.008.
Control of stochastic gene expression by host factors at the HIV promoter.
Burnett J, Miller-Jensen K, Shah P, Arkin A, Schaffer D
PLoS Pathog. 2009; 5(1):e1000260.
PMID: 19132086
PMC: 2607019.
DOI: 10.1371/journal.ppat.1000260.